Vision rehab and depression in age-related macular degeneration
Part of Eyes & vision, Mental health clinical trials.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 55 years of age or older.
- You have moderate to severe vision loss (visual acuity between 1/10 and 2/10).
- You have been diagnosed with advanced dry age-related macular degeneration (AMD).
- You are willing to follow the study procedures and sign a consent form.
- You do not have other eye diseases causing vision loss, and you are not completely blind or have very mild vision loss.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at something called 'visual frailty' in older adults with advanced age-related macular degeneration (AMD). It aims to develop a tool to better understand how vision loss affects daily life and overall health in people aged 60 and over.
This trial tests if repeated low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a condition that causes gradual vision loss. The therapy uses red light to potentially slow or improve vision problems.
This study tests how different types of artificial lighting affect vision in people with dry age-related macular degeneration (AMD). It may help find ways to improve daily visual comfort and function.
This trial studies a vision rehabilitation approach for veterans who have vision loss from age-related macular degeneration. The goal is to see whether the training improves how well people can use vision despite their eye condition.
This trial tests a new approach to improve vision in people with end-stage age-related macular degeneration (AMD). It aims to help those whose vision has dropped to a moderate or severe level, even with glasses, and who are not contact lens wearers.
This study uses virtual reality tests to see if they can measure vision changes in people with age-related macular degeneration (AMD), a condition that affects central vision. It compares results from healthy volunteers and people at different stages of AMD.
Hear when a new Anxiety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.